Intrinsiqs

Is Braveheart Bio, Inc. overvalued?

Braveheart Bio, Inc. (BRVE) — key valuation metrics and fundamentals.

No verdict
Price
$25.16
Fair value
Current P/E
Normal P/E
Market cap
$1.78B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares BRVE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 13 Aug 2026.